The potential neuroprotection mechanism of GDNF in the 6-ohda-induced cellular models of Parkinson's disease

Cellular and Molecular Neurobiology

Volumn 33, Issue 7, 2013, Pages 907-919

  Li, Feng ^a   Wang, Meng ^a   Zhu, Shuan ^a   Li, Li ^a   Xiong, Ye ^a   Gao, Dian Shuai ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

6 OHDA; Apoptosis; Dopaminergic cell line MN9D; GDNF; Microarray

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; OXIDOPAMINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

AGER GENE; ANIMAL CELL; ARTICLE; CCNL2 GENE; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; MICROARRAY ANALYSIS; MOUSE; NERVE CELL; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; UPREGULATION; VALIDATION STUDY; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL LINE; CLUSTER ANALYSIS; CYCLINS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; MICE; MODELS, BIOLOGICAL; NEUROPROTECTIVE AGENTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDOPAMINE; PARKINSON DISEASE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, IMMUNOLOGIC; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION;

EID: 84885183140     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-013-9957-0     Document Type: Article

References (37)

1. Alves M, Calegari VC, Cunha DA et al (2005) Increased expression of advanced glycation end-products and their receptor, and activation of nuclear factor kappa-B in lacrimal glands of diabetic rats. Diabetologia 48:2675-2681
2. Bruchas MR, Macey TA, Lowe JD et al (2006) Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes. J Biol Chem 281:18081-18089
3. Cao JP, Wang HJ, Yu JK et al (2008) The involvement of NF-kappaB p65/p52 in the effects of GDNF on DA neurons in early PD rats. Brain Res Bull 76:505-511
4. Cao JP, Niu HY, Wang HJ et al (2013) NF-κB p65/p52 plays a role in GDNF up-regulating Bcl-2 and Bcl-w expression in 6-OHDA-induced apoptosis of MN9D cell. Int J Neurosci. doi: 10.3109/00207454.2013.795149
5. Cavanaugh JE, Jaumotte JD, Lakoski JM et al (2006) Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response tooxidative stress. J Neurosci Res 84:1367-1375
6. Choi HK, Won LA, Kontur PJ et al (1991) Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion. Brain Res 552:67-76
7. Consales C, Volpicelli F, Greco D et al (2007) GDNF signaling in embryonic midbrain neurons in vitro. Brain Res 1159:28-39
8. Ding YM, Jaumotte JD, Signore AP et al (2004) Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor. J Neurochem 89:776-787
9. Drinkut A, Tereshchenko Y, Schulz JB et al (2012) Efficient gene therapy for Parkinson's disease using astrocytes as hosts for localized neurotrophic factor delivery. Mol Ther 20:534-543
10. Du Y, Li X, Yang D et al (2008) Multiple molecular pathways are involved in the neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration in vivo. Exp Biol Med 233:881-890
11. Encinas M, Tansey MG, Tsui-Pierchala BA et al (2001) c-Src is required for glial cell line-derived neurotrophic factor (GDNF) family ligand-mediated neuronal survival via a phosphatidylinositol-3 kinase (PI-3K)-dependent pathway. J Neurosci 21:1464-1472
12. Eslamboli A, Georgievska B, Ridley RM et al (2005) Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease. J Neurosci 25:769-777
13. Hetman M, Cavanaugh JE, Kimelman D et al (2000) Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal. J Neurosci 20:2567-2574
14. Holtz WA, Turetzky JM, O'Malley KL (2005) Microarray expression profiling identifies early signaling transcripts associated with 6-OHDA-induced dopaminergic cell death. Antioxid Redox Signal 7:639-648
15. Imai Y, Soda M, Inoue H et al (2001) An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell 105:891-902
16. Ischiropoulos H, Beckman JS (2003) Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J Clin Invest 111:163-169
17. Kang R, Tang D, Livesey KM et al (2011) The Receptor for Advanced Glycation End-products (RAGE) protects pancreatic tumor cells against oxidative injury. Antioxid Redox Signal 15:2175-2184
18. Kim IS, Choi DK, Jung HJ (2011) Neuroprotective effects of vanillyl alcohol in Gastrodia elata Blume through suppression of oxidative stress and anti-apoptotic activity in toxin-induced dopaminergic MN9D cells. Molecules 16:5349-5361
19. Lansbury PT Jr, Brice A (2002) Genetics of Parkinson's disease and biochemical studies of implicated gene products. Curr Opin Genet Dev 12:299-306
20. Lausson S, Cressent M (2011) Signal transduction pathways mediating the effect of adrenomedullin on osteoblast survival. J Cell Biochem 112:3807-3815
21. Mattson MP (2000) Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 1:120-129
22. Miyashita K, Itoh H, Arai H et al (2006) The neuroprotective and vasculo-neuro-regenerative roles of adrenomedullin in ischemic brain and its therapeutic potential. Endocrinology 147:1642-1653
23. Morrison TB, Weis JJ, Wittwer CT (1998) Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques 24:954-958
24. Park B, Oh CK, Choi WS et al (2011) Microarray expression profiling in 6-hydroxydopamine-induced dopaminergic neuronal cell death. J Neural Transm 118:1585-1598
25. Pascual A, Hidalgo-Figueroa M, Gómez-Díaz R et al (2011) GDNF and protection of adult central catecholaminergic neurons. J Mol Endocrinol 46:R83-R92
26. Perrinjaquet M, Vilar M, Ibáñez CF (2010) Protein-tyrosine phosphatase SHP2 contributes to GDNF neurotrophic activity through direct binding to phospho-Tyr687 in the RET receptor tyrosine kinase. J Biol Chem 285:31867-31875
27. Pieczenik SR, Neustadt J (2007) Mitochondrial dysfunction and molecular pathways of disease. Exp Mol Pathol 83:84-92
28. Ryu EJ, Harding HP, Angelastro JM et al (2002) Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. J Neurosci 22(24):10690-10698
29. Shimura H, Hattori N, Kubo S et al (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 25:302-305
30. Su CM, Lu DY, Hsu CJ et al (2009) Glial cell-derived neurotrophic factor increases migration of human chondrosarcoma cells via ERK and NF-kappaB pathways. J Cell Physiol 220:499-507
31. Tanabe K, Matsushima-Nishiwaki R, Iida M et al (2012) Involvement of phosphatidylinositol 3-kinase/Akt on basic fibroblast growth factor-induced glial cell line-derived neurotrophic factor release from rat glioma cells. Brain Res 1463:21-29
32. Ugarte SD, Lin E, Klann E et al (2003) Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: modulation by inhibitors of PI3 kinase and MEK. J Neurosci Res 73:105-112
33. Watanabe S, Ichimura T, Fujita N et al (2003) Methylated DNA-binding domain 1 and methylpurine-DNA glycosylase link transcriptional repression and DNA repair in chromatin. Proc Natl Acad Sci 100:12859-12864
34. Worby CA, Vega QC, Zhao Y et al (1996) Glial cell line-derived neurotrophic factor signals through the RET receptor and activates mitogen-activatedprotein kinase. J Biol Chem 271:23619-23622
35. Yang L, Li N, Wang C et al (2004) Cyclin L2, a novel RNA polymerase II-associated cyclin, is involved in pre-mRNA splicing and induces apoptosis of human hepatocellular carcinoma cells. J Biol Chem 279:11639-11648
36. Zhou A, Ou AC, Cho A et al (2008) Novel splicing factor RBM25 modulates Bcl-x pre-mRNA 5′ splice site selection. Mol Cell Biol 28:5924-5936
37. Zhuo L, Gong J, Yang R et al (2009) Inhibition of proliferation and differentiation and promotion of apoptosis by cyclin L2 in mouse embryonic carcinoma P19 cells. Biochem Biophys Res Commun 390:451-457